These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29980706)

  • 21. IgG4-related disease in a multi-ethnic community: clinical characteristics and association with malignancy.
    Poo SX; Tham CSW; Smith C; Lee J; Cairns T; Galliford J; Hamdulay S; Jacyna M; Levy JB; McAdoo SP; Roufosse C; Wernig F; Mason JC; Pusey CD; Tam FWK; Tomlinson JAP
    QJM; 2019 Oct; 112(10):763-769. PubMed ID: 31225617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study.
    Zongfei J; Lingying M; Lijuan Z; Ying S; Rongyi C; Dongmei L; Xiufang K; Xiaomin D; Lili M; Huiyong C; Lindi J
    Clin Rheumatol; 2021 Jun; 40(6):2293-2300. PubMed ID: 33151477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients.
    Wang L; Zhang P; Zhang X; Lin W; Tang H; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Zhang L; Lai Y; Zeng X; Li X; Xue H; Zhao Y; Zhang F; Zhang W
    Rheumatology (Oxford); 2019 May; 58(5):820-830. PubMed ID: 30561747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: results from the SMART database.
    Yamamoto M; Yajima H; Takahashi H; Yokoyama Y; Ishigami K; Shimizu Y; Tabeya T; Suzuki C; Naishiro Y; Takano K; Yamashita K; Hashimoto M; Keira Y; Honda S; Abe T; Suzuki Y; Mukai M; Himi T; Hasegawa T; Imai K; Shinomura Y
    Mod Rheumatol; 2015 Mar; 25(2):199-204. PubMed ID: 25159154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China.
    Zhao Z; Mou D; Wang Z; Zeng Q; Wang Z; Xue J; Ren L; Liu Y; Su Y
    Arthritis Res Ther; 2021 Mar; 23(1):98. PubMed ID: 33789746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and safety of mizoribine for the treatment of IgG4-related disease: a retrospective cohort study.
    Fukui S; Kawaai S; Nakai T; Suda M; Ikeda Y; Nomura A; Tamaki H; Kishimoto M; Ohde S; Okada M
    Rheumatology (Oxford); 2021 Dec; 60(12):5697-5704. PubMed ID: 33723568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial.
    Yunyun F; Yu P; Panpan Z; Xia Z; Linyi P; Jiaxin Z; Li Z; Shangzhu Z; Jinjing L; Di W; Yamin L; Xiaowei L; Huadan X; Xuan Z; Xiaofeng Z; Fengchun Z; Yan Z; Wen Z
    Rheumatology (Oxford); 2019 Jan; 58(1):52-60. PubMed ID: 30124952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of new organ onset in recurrent immunoglobulin G4-related disease during 10 years of follow-up.
    Liu Z; Peng Y; Li J; Lu H; Peng L; Zhou J; Zhou S; Huang C; Wang M; Zhu L; Chen H; Wang L; Fei Y; Zhao Y; Zeng X; Zhang W
    J Intern Med; 2022 Jul; 292(1):91-102. PubMed ID: 35419810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for extraophthalmic involvement and treatment outcomes in patients with IgG4-related ophthalmic disease.
    Park J; Lee MJ; Kim N; Kim JE; Park SW; Choung HK; Khwarg SI
    Br J Ophthalmol; 2018 Jun; 102(6):736-741. PubMed ID: 28972022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease.
    Soriano Rios A; Paredes H; Hernández-Calleros J; Uscanga-Domínguez L; Peláez-Luna M
    Med Hypotheses; 2019 Jan; 122():120-123. PubMed ID: 30593393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment outcomes in IgG4-related disease.
    Karim AF; Bansie RD; Rombach SM; Paridaens D; Verdijk RM; van Hagen PM; Van Laar JAM
    Neth J Med; 2018 Aug; 76(6):275-285. PubMed ID: 30152392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of disease relapse in IgG4-related disease following rituximab.
    Wallace ZS; Mattoo H; Mahajan VS; Kulikova M; Lu L; Deshpande V; Choi HK; Pillai S; Stone JH
    Rheumatology (Oxford); 2016 Jun; 55(6):1000-8. PubMed ID: 26888853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of Immunoglobulin G4-related Disease during Chemotherapy for Advanced Breast Cancer.
    Fujii Y; Doi M; Yamane H; Morioka T; Komichi D; Nishisaka T; Shinozaki K
    Intern Med; 2020 Jul; 59(13):1649-1654. PubMed ID: 32269187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease.
    Campochiaro C; Della-Torre E; Lanzillotta M; Bozzolo E; Baldissera E; Milani R; Arcidiacono PG; Crippa S; Falconi M; Dagna L
    Eur J Intern Med; 2020 Apr; 74():92-98. PubMed ID: 31901297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nivolumab Therapy in Lung Cancer Associated with IgG4-related Disease.
    Aso M; Suzuki H; Aizawa T; Nawa S; Ota H; Nogawa H; Hino T
    Intern Med; 2024 Jan; 63(2):283-287. PubMed ID: 37258169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review.
    Wang Y; Li K; Gao D; Luo G; Zhao Y; Wang X; Zhang J; Jin J; Zhao Z; Yang C; Zhu J; Zhang J; Huang F
    Intern Med J; 2017 Jun; 47(6):680-689. PubMed ID: 28321964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study.
    Ozeki T; Ando M; Yamaguchi M; Katsuno T; Kato S; Yasuda Y; Tsuboi N; Maruyama S
    PLoS One; 2018; 13(6):e0199228. PubMed ID: 29912938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The histological diagnosis of IgG4-related disease on small biopsies: challenges and pitfalls.
    Arora K; Rivera M; Ting DT; Deshpande V
    Histopathology; 2019 Apr; 74(5):688-698. PubMed ID: 30408214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids.
    Yunyun F; Yu C; Panpan Z; Hua C; Di W; Lidan Z; Linyi P; Li W; Qingjun W; Xuan Z; Yan Z; Xiaofeng Z; Fengchun Z; Wen Z
    Sci Rep; 2017 Jul; 7(1):6195. PubMed ID: 28733656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis.
    Arao T; Okada Y; Torimoto K; Kurozumi A; Narisawa M; Yamamoto S; Tanaka Y
    J UOEH; 2015 Jun; 37(2):103-10. PubMed ID: 26073499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.